PRN.TO

Profound Medical Corp.

C$10.60

0.66%

SectorHealthcareIndustryMedical DevicesCountryCanadaExchangeTSX · CADAlso trades asPROF

Overview AI Brief ChartChart & Performance Financials ExposureRevenue Exposure FilingsFilings & Red Flags ScoresScores & Valuation News Analysts InsidersInsiders & Short Interest Ownership

Market CapC$388.2M

Dividend Yield0.00%

Beta0.56

AI summary

Price & performance

1M+6.1%

3M+13.2%

YTD+0.5%

1Y+17.3%

52-week range—

Beta0.56

Full chart and returns against a benchmark

Q-Score

48/ 100

Quality against peers; 50 is the peer median.

Growth72

Risk57

Performance47

Valuation38

Profitability44

Leverage43

Sentiment—

Every score and metric

News sentiment

Open News

Latest results · FY 2025

RevenueC$22M+57.7%

Net income-C$58.3M

Net margin-264.4%+21.1 pts

Historical fundamentals

Valuation

PRN.TOIndustryP/E—29.62P/S11.413.49EV/EBITDA—18.39P/B6.443.39PEG——

Dividend yield0.00%

Every valuation metric

Historical Fundamentals

Revenue

Net Income

Net Margin

Showing the last 4 periods. Pro adds the full annual and quarterly history and 20+ more metrics to chart.

Latest Results

The latest fiscal year and quarter, each against the same period a year earlier, from SEC filings.

Metric	FY 2025	vs a year before	Q3 2026	vs a year before
Revenue	C$22M	+57.7%	C$14M	—
Net Income	-C$58.3M	—	-C$11M	—
Net Margin	-264.4%	+21.1 pts	-78.6%	—

Obligations & Notes

From the notes to the annual report for fiscal 2025, ending December.

Lease liabilitiesC$291.7K

Q-Scores

OverallCombines the categories below, except Sentiment

Industry 5348

Growth

Industry 4972

Risk

Industry 6957

Performance

Industry 4747

Valuation

Industry 4638

Profitability

Industry 5544

Leverage

Industry 6043

Key Metrics

Fundamentals: trailing twelve months to Sep 2026, from the latest 10-K and 10-Qs.

Market Beta (5-factor)

IM 0.86SM 0.770.83

Market Cap

272.1M

Dividend Yield

IM 0.00%SM 0.00%0.00%

Volume

IM 547.8KSM 673.8K15.7K

Industry Market Share

0.03%

Sector Market Share

0.00%

IM industry median · SM sector median: the typical company the value is compared with. The /100 is its score against those peers.

Comparable Companies

The companies closest in size in Medical Devices (filled from its sector when there are few), with the median and rank across all 139 in the industry.

Company	Market cap	P/E	EV/EBITDA	P/S	P/B	FCF yield	Implied growth	Revenue growth	Op. margin	ROE	Debt/equity
PRN.TOProfound Medical Corp.	$272.1M	—	—	11.4	6.4	-11.3%	—	76.3%	-139.6%	-74.5%	0.2
CLPTClearPoint Neuro, Inc.	$271.8M	—	—	6.0	10.0	-12.2%	—	32.5%	-70.6%	-132.5%	1.9
PROFProfound Medical Corp.	$271.8M	—	—	11.2	6.4	-11.7%	—	81.7%	-140.7%	-76.4%	0.2
LABStandard BioTools Inc.	$279.3M	2.1	—	3.3	0.5	-23.5%	—	-2.2%	-97.5%	23.9%	0.0
NPCENeuroPace, Inc.	$260.5M	—	—	2.4	22.7	-4.8%	—	29.2%	-9.5%	-164.6%	5.1
OFIXOrthofix Medical Inc.	$292.2M	—	13.2	0.3	0.7	-15.2%	—	2.1%	-2.5%	-10.5%	0.5
QSIQuantum-Si incorporated	$252.7M	—	—	199.8	1.6	-32.2%	—	-60.2%	—	-53.1%	0.0
INFUInfuSystem Holdings, Inc.	$294.9M	31.2	11.3	2.0	4.6	8.4%	-0.8%	2.4%	9.8%	14.7%	0.3
PAIN.VVector Science and Therapeutics Corp.	$316.7M	—	—	—	164.0	-0.2%	—	—	—	-44.8%	0.0
Industry median		25.2	18.7	2.4	2.5	-7.5%	11.4%	11.7%	-13.1%	-25.3%	0.0
PRN.TO percentile		—	—	92nd	78th	46th	—	90th	18th	32nd	59th